1. Home
  2. PTGX vs GDRX Comparison

PTGX vs GDRX Comparison

Compare PTGX & GDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • GDRX
  • Stock Information
  • Founded
  • PTGX 2006
  • GDRX 2011
  • Country
  • PTGX United States
  • GDRX United States
  • Employees
  • PTGX N/A
  • GDRX N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • GDRX Retail: Computer Software & Peripheral Equipment
  • Sector
  • PTGX Health Care
  • GDRX Technology
  • Exchange
  • PTGX Nasdaq
  • GDRX Nasdaq
  • Market Cap
  • PTGX 2.8B
  • GDRX 3.1B
  • IPO Year
  • PTGX 2016
  • GDRX 2020
  • Fundamental
  • Price
  • PTGX $46.46
  • GDRX $4.90
  • Analyst Decision
  • PTGX Strong Buy
  • GDRX Buy
  • Analyst Count
  • PTGX 7
  • GDRX 16
  • Target Price
  • PTGX $53.57
  • GDRX $9.03
  • AVG Volume (30 Days)
  • PTGX 784.4K
  • GDRX 2.2M
  • Earning Date
  • PTGX 11-07-2024
  • GDRX 11-07-2024
  • Dividend Yield
  • PTGX N/A
  • GDRX N/A
  • EPS Growth
  • PTGX N/A
  • GDRX N/A
  • EPS
  • PTGX 2.68
  • GDRX N/A
  • Revenue
  • PTGX $323,795,000.00
  • GDRX $790,385,000.00
  • Revenue This Year
  • PTGX $396.93
  • GDRX $8.50
  • Revenue Next Year
  • PTGX N/A
  • GDRX $7.95
  • P/E Ratio
  • PTGX $17.31
  • GDRX N/A
  • Revenue Growth
  • PTGX 125.73
  • GDRX 7.14
  • 52 Week Low
  • PTGX $16.80
  • GDRX $4.09
  • 52 Week High
  • PTGX $48.89
  • GDRX $9.26
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 57.05
  • GDRX 40.12
  • Support Level
  • PTGX $33.31
  • GDRX $4.11
  • Resistance Level
  • PTGX $48.86
  • GDRX $6.28
  • Average True Range (ATR)
  • PTGX 3.02
  • GDRX 0.34
  • MACD
  • PTGX -0.16
  • GDRX -0.00
  • Stochastic Oscillator
  • PTGX 84.57
  • GDRX 36.99

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About GDRX GoodRx Holdings Inc.

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

Share on Social Networks: